Podcasts about genetic data

Learn how the Genetic Data Partner (GDP) Program from Select Sires helps drive dairy genetic progress through real-world data collection and young sire sampling. In this episode, Preston Sheets, Dairy Development Programs Advisor, explains how partner herds contribute fertility, production and type data to develop more reliable, proven sires. Discover how the program benefits producers with early access to genetics while shaping the future of the dairy industry.

In this episode, Michel Mommejat, President of A.D.A.M. Innovations, shares how genomics and AI are transforming healthcare from reactive treatment to preventative wellcare. Recorded in Tokyo, this conversation explores what your DNA can reveal as a biological blueprint, why Japan serves as the world's laboratory for healthy aging, and how combining genetic data with biomarkers and lifestyle information creates a dynamic, personalized health ecosystem. Michel also discusses the ethical frameworks needed to protect the most sensitive data that exists, the concept of Artificial General Gene Intelligence, and practical applications like pharmacogenomics that are already changing how we think about medication. Tune in for a visionary conversation on the future of health and longevity.

Dr. Alex Kotlar is a geneticist, bioinformatics leader, and technology founder with nearly 20 years of combined experience across life sciences, healthcare, AI, and software engineering.He is the Co-Founder and CEO of Bystro AI, a platform designed to make large-scale genetic data easy to search and analyse using natural language, similar to how people use Google or ChatGPT.Read more about Alex Kotlar: https://businessabc.net/wiki/alex-kotlarAlex Kotlar interview questions00:00 Introduction03:43 - Background12:50 - The inspirations in life22:21 - Genetics with tech29:30 - How smart is AI?34:26 - What is Bystro.io?42:29 - Agentic AI for genetics47:38 - Bystro case studies51:00 - Genome Biology53:37 - AI in genetics & healthcare01:04:18 - Personalised Healthcare01:18:27 - Individual vs enterprise research01:21:21 - Roadmap for Bystro01:25:13 - Digital twin for personalised healthcare01:34:07 - ClosureUseful Links and Resourceshttps://www.linkedin.com/in/alexkotlarhttps://bystro.io/teamAbout businessabc.nethttps://www.businessabc.net/About citiesabc.comhttps://www.citiesabc.com/​​​​​​​​​​​ About Dinis Guardahttps://www.dinisguarda.com/https://businessabc.net/wiki/dinis-guardaBusiness Inquiries- info@ztudium.comSupport the show

Genetic testing has had some ups and downs over the past few years, with wide swaths of data sets setting a precedent for potential individualized healthcare. But, oftentimes, that data misrepresents African-descended individuals and doesn't paint the whole picture. Population geneticist Dr. Janina Jeff Ringo joins host Dr. Samantha Yammine to discuss what we can learn from genetic testing, and the gaps that sociologists are trying to fill in. Sam also explores a fascinating new study that claims to have nailed down the perfect cacio e pepe recipe and a potential solution to the growing strain on global rice yields. Link to Show Notes HERE Follow Curiosity Weekly on your favorite podcast app to get smarter with Dr. Samantha Yammine — for free! Still curious? Get science shows, nature documentaries, and more real-life entertainment on discovery+! Go to https://discoveryplus.com/curiosity to start your 7-day free trial. discovery+ is currently only available for US subscribers. Hosted on Acast. See acast.com/privacy for more information.

Gideon Nave, Wharton Associate Professor of Marketing, explores the complex intersection of personal autonomy, informed consent, and societal benefit as 23andMe's bankruptcy raises urgent questions about the fate and control of sensitive genetic information. Hosted on Acast. See acast.com/privacy for more information.

In this episode of the Joe Cohen Show, host Joe Cohen discusses the power of biohacking and precision health with Sasha Powell, a nurse practitioner and integrative healthcare provider. Sasha shares her experience using DNA data to optimize her patients' health outcomes, focusing on areas like hormone and weight management, mental health, and overall well-being. They dive into the specifics of how genetic insights can personalize treatment plans, leading to better, faster results. Whether it's diagnosing mental health issues more accurately or managing physical health conditions like diabetes and inflammation, Sasha highlights the transformative impact of personalized medicine. Tune in to understand why integrating genetic information into healthcare is not just an innovation but a necessity.- Check out SelfDecode: https://selfdecode.com/- Join Joe's online community: https://thejoecohenshow.com/ Timestamp:(00:00) - Introduction to the Joe Cohen Show(00:16) - Meet Sasha Powell(00:56) - Using DNA for Personalized Health Solutions(01:24) - Weight and Hormone Management Strategies(03:11) - Blood Sugar Regulation and Diet Recommendations(07:25) - Mental Health and Genetic Insights(10:59) - The Role of Neurochemistry in Treatment Plans(13:48) - Personalized Supplement Recommendations(30:10) - The Importance of Methylation in Health(34:03) - Utilizing Self Decode for Comprehensive Health Management(38:31) - Optimizing Quality of Life(39:06) - Longevity Screener Insights(39:34) - Clinical Overview Report(40:30) - Health Overview Report(41:44) - Lab Data and Clinical Recommendations(45:15) - Family Planning and Genetic Risks(45:57) - Integrating Lab Tests and Genetic Data(48:44) - Using SelfDecode in Clinical Practice(58:56) - The Future of Healthcare with AI(01:04:26) - Organic Acids Test and Lab Considerations(01:08:08) - Concluding Thoughts and Recommendations

The recent bankruptcy of genetic testing firm 23andMe has raised alarm bells for privacy advocates and consumers worried about their personal information. The data managed by 23andMe could eventually be used in any number of negative or nefarious ways, from discrimination to executing a sophisticated scam. And to be clear, this isn't just a 23andMe problem. Bankruptcy and data theft are just as much a risk with other DNA testing firms. So, what should people know about privacy and genetic data security? Kayte Spector Bagdady, a member of the health law and bioethics faculty at the University of Michigan, joins The Excerpt to share a legal and medical perspective.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Almost two decades after it entered the market, commercial genetic testing provider 23andMe filed for bankruptcy, earlier this year. Its demise has revived debate about genetic testing, which in its early days promised a revolution in medical treatment. Has that really happened?

This week – after a quick check in on their March Madness brackets – Nate and Maria discuss Trump’s showdown with the Ivy League. Should schools like Harvard and Columbia do more to stand up to the President’s demands? Then they turn to 23andMe, which has declared bankruptcy. They discuss privacy and whether it’s okay to swap your biometric data for more convenience at the airport. Last but not least, they tackle the question of how to properly value your time. Further Reading: Kashmir Hill’s Your Face Belongs To Us Sendhil Mullianathan’s research on time poverty For more from Nate and Maria, subscribe to their newsletters: The Leap from Maria Konnikova Silver Bulletin from Nate Silver Get ad-free episodes, and get your questions answered in an exclusive weekly bonus episode, of Risky Business by subscribing to Pushkin+ on Apple Podcasts or Pushkin.fm. Pushkin+ subscribers can access ad-free episodes, full audiobooks, exclusive binges, and bonus content for all Pushkin shows. Subscribe on Apple: apple.co/pushkinSubscribe on Pushkin: pushkin.fm/plusSee omnystudio.com/listener for privacy information.

Lisa Gibson, organizer of Indivisible Hawaiʻi, shares details on an upcoming statewide protest against the actions of the Trump administration; the state Office of Consumer Protection advises listeners on how to safeguard their genetic data

David Holtzman and David Carvalho from Naoris Protocol delve into the recent bankruptcy of 23andMe, a leading genetic testing company. They explore the implications for data security and privacy, discussing how the sale of 23andMe's vast genetic database raises concerns about the protection of personal information. 

23andMe, the San Francisco tech company known for its direct-to-consumer genetic testing, announced Sunday it filed for Chapter 11 bankruptcy. That’s raised a lot of privacy concerns over the genetic records it holds of roughly 15 million customers. The company said that while in bankruptcy court, that data will be handled with the same level of privacy. But California Attorney General Rob Bonta released a statement that suggested Californians should consider “directing 23andMe to delete their data and destroy any samples of genetic material.” Guest: Washington Post tech columnist Geoffrey Fowler Related Links: Delete your DNA data from genetics company 23andMe right now - The Washington Post How to delete your 23andMe data after the company filed for bankruptcy Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes Soundside is a production of KUOW in Seattle, a proud member of the NPR Network.See omnystudio.com/listener for privacy information.

Utah AG warns Utahns to delete genetic data after 23andMe bankruptcy announcement -- Pine Creek ski resort spotlight -- Cox vetoes property tax change bill

- Trump Administration's Nomination of Susan Monar to Head the CDC (0:10) - Concerns Over Dr. Monar's Tweets and CDC Directorship (2:33) - 23andMe's Bankruptcy and Data Weaponization (4:15) - Health Insurance and Law Enforcement Implications (17:14) - Multigenerational Impact of 23andMe's Data Sharing (19:37) - Trump Administration's Failures and Incompetence (20:19) - Lack of Accountability and Transparency (45:12) - Impact of Left-Wing Judges on Trump's Agenda (46:51) - Criticism of Susan Monar's Nomination to CDC (54:12) - Trump's Involvement in Crypto and ETFs (57:30) - Health Ranger Store Products and Music Announcement (1:09:45) - Introduction of Guests and Show Theme (1:27:28) - Food Forest Abundance and Practical Steps for Decentralization (1:30:34) - Permaculture and Stewardship Principles (1:34:31) - Challenges and Solutions for Urban Food Production (1:41:22) - Medicinal Properties of Plants and Food Forest Design (1:57:23) - Community and Educational Initiatives (2:02:24) - Technological Advancements and Automation in Food Production (2:09:00) - Investment in Food Forests and Long-Term Benefits (2:19:27) - Conclusion and Call to Action (2:27:15) For more updates, visit: http://www.brighteon.com/channel/hrreport NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

As 23andMe's bankruptcy looms, privacy experts warn customers to delete their DNA data. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Plus - Barack Obama joins Bluesky; Apple is bringing lossless audio and low-latency audio to AirPods Max Learn more about your ad choices. Visit podcastchoices.com/adchoices

Sara Gerkeis an associate professor of law at the University of Illinois Urbana-Champaign. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S. Gerke, M.B. Jacoby, and I.G. Cohen. Bankruptcy, Genetic Information, and Privacy — Selling Personal Information. N Engl J Med 2025;392:937-939.

Dairy farmers now have a powerful new way to enhance their genetic programs with an innovative embryo tracking system. This technology simplifies managing embryo inventory and tracking genetic data, enabling farmers to improve herd performance efficiently. It's called the embryo inventory module. Melissa Freitas, West & Northeast FPC Team Leader for VAS, emphasizes how this tool fills a crucial gap in data management. "Farmers need a reliable way to record and analyze genetic data," Freitas explains. "This module consolidates everything—from embryo inventory to calf performance—into one easy-to-use system." See omnystudio.com/listener for privacy information.

In this episode of Vibe Science, hosts Ryan Alford and Chris Hansen dive into the world of biohacking and personalized health with Joe Cohen, founder of SelfDecode. Joe shares his personal journey, detailing how he uses genetic data to make smarter health decisions and enhance overall well-being. The conversation delves into his extensive supplement routine, the significance of understanding genetic predispositions, and how data-driven strategies can revolutionize health optimization. This episode showcases the transformative power of biohacking and genetic testing, inspiring listeners to harness technology for a more informed and proactive approach to their health.TAKEAWAYSExploration of biohacking and personalized health optimization.Discussion on the importance of understanding genetic data for health decisions.Overview of an extensive supplement regimen and its alignment with personal health goals.Emphasis on the complexity of health decisions and the need for a data-driven approach.Introduction to SelfDecode and its role in providing genetic analysis and health recommendations.Insights into the challenges of navigating the health and wellness industry.The significance of personalized health strategies tailored to individual needs.The proposal for DNA testing to enhance transparency in health journeys.Clarification of the distinction between biohackers and medical professionals.Future possibilities in health optimization through technology and data. Follow us on Instagram: @Vibe.Science Subscribe to our YouTube Page: www.youtube.com/@Vibe.Science

What happens when the companies holding your most sensitive data start to falter? Sarah is joined by Drex to dive into the alarming challenges facing 23andMe and Atlas Biomed, two major players in genetic testing. Explore the intersection of data privacy, financial instability, and the unique risks of DNA testing. From data breaches to the ethical implications for health systems, this episode uncovers why the stakes are higher than ever for healthcare leaders. Subscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on the association between periodontal disease and cardiovascular disease, including insights from imaging, observational, and genetic data.

One of the world's most popular genetic sequencing companies, 23andMe, is on the brink of bankruptcy. It holds the genetic data of more than 15 million customers - including New Zealanders.

And here's how to remove yourself from 23andMe.

One underappreciated fact about the explosion in genetic databases, like consumer sites that provide information about ancestry and health, is that they unlock valuable insights not only into an individual's past and future, but also for that individual's entire family.This raises serious concerns about privacy for people who have never submitted their genetic information for analysis, yet share much the same code as one who did.This week on If/Then, we're sharing an interview from The Future of Everything with Stanford GSB Professor Kuang Xu. Xu is an expert in how genetic information can and should be used. He says that the DNA problem weighs heavily on privacy experts in fields ranging from law and engineering to public health and criminal justice. The fundamental question is: Can we create methods for accessing genetic data while maximizing the privacy of all involved?The Future of Everything is Produced by Stanford Engineering. For a full transcript of this episode, visit The Future of Everything's website.Chapters:(00:00:00) IntroductionHost Kevin Cool introduces an episode featuring The Future of Everything podcast with host Russ Altman and guest Kuang Xu, a professor at the GSB. (00:03:24) Genetic Technology and Privacy RisksThe key ideas and methodology behind making genetic searches more private.(00:06:23) Social Network and Genealogy in Genetic SearchesHow a genealogy network functions as a social network in genetic searches.(00:09:23) Technical Aspects of Securing Genetic DataThe difference between sequential and static methods for genetic searches.(00:11:19) Practical Application of Sequential MethodsWays the sequential search method could be applied without compromising privacy.(00:12:43) First Steps in Sequential SearchWhat the first steps would look like when using the sequential search method.(00:14:41) Balancing Accuracy and PrivacyWhether the new privacy methods compromise accuracy in identifying individuals.(00:15:22) Applications in Genetic ResearchHow privacy methods can apply to genetic research for disease prediction and beyond.(00:18:22) Insights During ResearchSurprise findings from Kuang's research on genetic privacy.(00:21:28) Privacy Beyond GeneticsThe possibility of applying these privacy techniques to other sensitive datasets.(00:22:58) Commercial Interest in Privacy SolutionsThe interest from companies in adopting these privacy innovations.(00:24:09) Genetics and Business School ConnectionKuang's work at Stanford's School of Business and how it connects to genetics and privacy.(00:25:30) Emergency Room Waiting TimesResearch related to reducing waiting times in emergency rooms.(00:26:57) In-Person Voting and COVID-19 SpreadOverview of data collected during in-person voting during COVID-19.(00:27:54) ConclusionSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today, I'm joined by Kian Sadeghi, founder & CEO of Nucleus Genomics. Since dropping out of UPenn in ‘21, Kian has raised $18M for complete DNA health tests. Democratizing whole-genome sequencing, he aims to save millions from preventable disease. In this episode, we discuss the company's trillion-dollar vision for the future of healthcare. We also cover: • Where preventative medicine is headed • Challenges in consumer healthtech • Building a breakthrough brand Subscribe to the podcast → insider.fitt.co/podcast Subscribe to our newsletter → insider.fitt.co/subscribe Follow us on LinkedIn → linkedin.com/company/fittinsider Nucleus Genomics Website: https://mynucleus.com/ IG: https://www.instagram.com/nucleusgenomics/ Twitter/X: https://x.com/nucleusgenomics LinkedIn: https://www.linkedin.com/company/nucleusgenomics/ -   The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart workout solutions for fitness and health facilities.  Fitt Talent: https://talent.fitt.co/ Consulting: https://consulting.fitt.co/ Investments: https://capital.fitt.co/ Chapters: (00:00) Introduction (01:50) Inspiration Behind Nucleus Genomics (03:07) Advancements in Genetic Testing Technology (04:40) Making Genetic Information Accessible and Actionable (06:48) The Process of Nucleus Genomics Testing (08:17) The Importance of Knowing Your Genetic Blueprint (09:19) Challenges and Opportunities in Genetic Testing (10:58) Nucleus Genomics' Vision for the Future (12:39) Integrating Health Data for Personalized Insights (16:45) The Unique Value of Whole Genome Data (20:47) The Importance of Preventative Health Measures (23:12) Partnerships (25:18) Addressing Medical Paternalism and Consumer Rights (27:36) Balancing Innovation with Healthcare Regulations (30:22) Nucleus' Mission and Future Goals (35:54) The Role of Genetic Data in Longevity (37:29) Scaling and Financing Nucleus (41:08) Conclusion

Data Privacy Attorney, John Ochoa, joins the show to discuss a recent lawsuit of a beverage giant under Illinois Genetic Privacy Law, and a Texas judge says drag shows aren't always protected by First Amendment, citing the “history and tradition” test, as the legal standard for his ruling. (00:00) - Intro (01:12) - Beverage giant sued under Illinois Genetic Privacy Law (28:46) - Justices using the controversial “history and tradition” test, as a legal standard in their rulings (42:45) - Outro

In this episode of ATP, Shambhavi Naik and Saurabh Todi discuss the recent completion of the 10,000 Genome Project and the importance of collecting such data for medical research. Do check out Takshashila's public policy courses: https://school.takshashila.org.in/courses We are @‌IVMPodcasts on Facebook, Twitter, & Instagram. https://twitter.com/IVMPodcasts https://www.instagram.com/ivmpodcasts/?hl=en https://www.facebook.com/ivmpodcasts/ You can check out our website at https://shows.ivmpodcasts.com/featured Follow the show across platforms: Spotify, Google Podcasts, Apple Podcasts, JioSaavn, Gaana, Amazon Music .Do share the word with your folks  See omnystudio.com/listener for privacy information.

Driven by curiosity, more and more people are turning to direct-to-consumer genetic testing sites to understand a little bit more about themselves. Law enforcement has been able to tap into this trove of information to help solve cold cases that are decades old. Experts share how the process works and whether there are ethical concerns about sharing one's genetic data online. With guests: Claire Glynn, associate professor of Forensic Science at the Henry C. Lee College of Criminal Justice and Forensic Sciences at the University of New Haven; Patricia Kosseim, Information and Privacy Commissioner of Ontario; Toronto Star crime reporter Jennifer Pagliaro; and Ellen White, investigator at Pulse Private Investigations and host of the podcast, "Whereabouts Unknown."See omnystudio.com/listener for privacy information.

This week, a data breach was disclosed by 23andMe, affecting 6.9 million users and compromising their genetic data information. The incident raises significant concerns about data privacy and security. It's important to note that while some perceive this as a violation of HIPAA, it typically doesn't apply to direct-to-consumer genetic testing services like 23andMe, as they don't involve covered entities such as physicians. This leaves a gap in privacy protection, and alternative legal frameworks, such as those enforced by the Federal Trade Commission, may come into play. However, actions against direct-to-consumer genetic testing companies by the FTC have been rare. The breach highlights the need for increased awareness and potentially new laws and regulations to safeguard sensitive genetic data in the rapidly evolving digital landscape.

Do you ever wonder what the intersection of biotech and geopolitics looks like? This episode ventures into the realm of genetic testing and the geopolitical implications of a lab gifted by China to Serbia. FireEye, a state-of-the-art lab, stands at the precipice of pushing the boundaries of what we know about viruses and human genomes. As this technology extends its reach across four continents, the consequences could be monumental, ranging from bio weapons, mass surveillance, to harvesting global genetic data. Strap yourselves in for this fascinating discussion on the possible repercussions of this development.As we navigate the profound complexities of biotechnology, we shed light on the ethical dilemmas arising from the analysis of genetic data. The rapid progress in biotechnology, accelerated by the COVID-19 pandemic, has flung open a Pandora's box of potential misuses and global geopolitical impact. We also venture into the realm of a potential hierarchical society where the affluent gain ascendance through genetic modifications. Switching lanes, we steer towards the world of electric vehicles, specifically into the impact of supercharging on EV batteries. We'll tread into the territory of battery degradation, advancements in technology to maximize battery life, and the different types of EV chargers. With the looming presence of giant oil companies like ExxonMobil and their potential push for alternative fuels, we dissect the trials and triumphs waiting in the future of EVs. So tune in, as we discourse on the electrifying journey of the future of mobility.Support the showLet's get into it!Follow us!Email us: TheCatchupCast@Gmail.com

Genome scientist and UC San Diego professor Keolu Fox uses genomic studies to decode Indigenous history, from migratory patterns to disease in these communities.

Whistleblower Report – Yellow Card biobank is a collaboration between the MHRA and Genomics England. Its goal is to improve understanding of how a patient's genetic makeup may increase their risk of harm from side effects. They are collecting your data but not presenting the methods to be used to correlate drug side effects with people's genetic makeup. Another journey into fantasy...

Infertility. It's real. It affects 10-15% of couples in the US. After a thorough investigation, 30% of couples will be left without an identifiable cause for their infertility. This has been termed unexplained infertility. While traditionally this may have been considered a reassuring result, new data is raising the yellow flag of caution in these patients. Research has now established the link between infertility and some potential future negative health outcomes. As “next generation“ genetic tests become more integrated into clinical practice, new data (released ahead of print on March 16, 2023 in the New England Journal of Medicine) has revealed some life-changing realities for couples struggling with unexplained infertility. In this episode, we will highlight the advances in genetic medicine and summarize the key findings of this eye-opening new publication.

Throughout the U.S., usually right after a baby is born, a doctor or nurse takes a pinprick of blood from the newborn — often from its cute, little feet — to screen for diseases or genetic defects. These blood tests are mandatory and create a health and genetic database. But who gets access to that genetic information, and for what purpose, is at the center of several legal fights. In New Jersey, the Office of the Public Defender recently sued the state testing program after police allegedly used a newborn’s blood sample to help them obtain a warrant for the father’s DNA. “Marketplace Tech’s” Kimberly Adams spoke with reporter Nikita Biryukov at the New Jersey Monitor, who broke the story.

Throughout the U.S., usually right after a baby is born, a doctor or nurse takes a pinprick of blood from the newborn — often from its cute, little feet — to screen for diseases or genetic defects. These blood tests are mandatory and create a health and genetic database. But who gets access to that genetic information, and for what purpose, is at the center of several legal fights. In New Jersey, the Office of the Public Defender recently sued the state testing program after police allegedly used a newborn’s blood sample to help them obtain a warrant for the father’s DNA. “Marketplace Tech’s” Kimberly Adams spoke with reporter Nikita Biryukov at the New Jersey Monitor, who broke the story.